Status:
RECRUITING
Protocol for a Research Sample Repository for Hematopoietic Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries
Lead Sponsor:
Center for International Blood and Marrow Transplant Research
Conditions:
Autologous Stem Cell Transplantation
Allogeneic Stem Cell Transplantation
Eligibility:
All Genders
Brief Summary
The primary purpose of the Research Sample Repository is to make blood samples available for research studies related to histocompatibility and hematopoietic cell transplantation (HCT) or other cellul...
Detailed Description
Research samples will be accepted from the following four categories: * Hematopoietic Cell or other Cellular Therapy Donors * Cord Blood Units * Hematopoietic Cell Transplantation or other Cellular T...
Eligibility Criteria
Inclusion
- Eligibility to participate in the Research Sample Repository Protocol:
- Hematopoietic Cell (HC) or Other Cellular Therapy Donors
- Donors are eligible to participate in the Research Sample Repository if they have donated or are scheduled to donate HCs or cellular therapy products to an allogeneic recipient either by a marrow harvest or by apheresis. This includes adults with and without decision making capacity and children.
- All donors registered on the National Marrow Donor Program (NMDP) Registry, regardless of whether they have been requested to donate a product for a patient, are eligible to participate in the Research Sample Repository.
- Cord Blood Units (CBUs)
- Testable material from CBUs (Specimens) infused at treatment centers covered under the C. W. Bill Young Transplantation Program are eligible for inclusion in the Research Sample Repository. Material may be submitted by participating treatment centers, centralized laboratories and Cord Blood Banks.
- Hematopoietic Cell Transplantation or Other Cellular Therapy Recipients
- All U.S. recipients of allogeneic or autologous HC transplants or cellular therapies are eligible to participate in the Research Sample Repository. This includes adults with and without decision making capacity and children.
- Patients with Marrow Toxic Injury
- Any patient who is treated for a marrow toxic injury at a center participating in the NMDP's Radiation Injury Treatment Network (RITN) is eligible to participate in the Research Sample Repository. This includes adults with and without decision-making capacity and children.
- Eligible patients may have received support care only, growth factor support, hematopoietic stem cell transplant or other appropriate medical treatment for marrow toxic injury
Exclusion
Key Trial Info
Start Date :
July 1 1991
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2030
Estimated Enrollment :
99999999 Patients enrolled
Trial Details
Trial ID
NCT04920474
Start Date
July 1 1991
End Date
July 1 2030
Last Update
May 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NMDP Biorepository
New Brighton, Minnesota, United States, 55112